Evidence map›Paper›PMID 32165615›Full record

ArticleNature communications2020

A receptor for the complement regulator factor H increases transmission of trypanosomes to tsetse flies.

Olivia J S Macleod, Jean-Mathieu Bart, Paula MacGregor, Lori Peacock, Nicholas J Savill, Svenja Hester, Sophie Ravel, Jack D Sunter, Camilla Trevor, Steven Rust and 7 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 2 countries.

Olivia J S MacleodDepartment of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QW, UK.ORCID http://orcid.org/0000-0002-5747-8019
Jean-Mathieu BartIntertryp, IRD, Cirad, University of Montpellier, Montpellier, France.ORCID http://orcid.org/0000-0001-5707-3778
Paula MacGregorDepartment of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QW, UK.ORCID http://orcid.org/0000-0003-0919-3745
Lori PeacockSchool of Biological Sciences, University of Bristol, Bristol, BS8 1UG, UK.
Nicholas J SavillInstitute for Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, King's Buildings, West Mains Road, Edinburgh, EH9 3JT, UK.ORCID http://orcid.org/0000-0002-9769-6168
Svenja HesterDepartment of Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU, UK.
Sophie RavelIntertryp, IRD, Cirad, University of Montpellier, Montpellier, France.
Jack D SunterDepartment of Biological and Medical Sciences, Oxford Brookes University, Gipsy Lane, Oxford, OX3 0BP, UK.ORCID http://orcid.org/0000-0002-2836-9622
Camilla TrevorDepartment of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QW, UK.
Steven RustDepartment of Antibody Discovery and Protein Engineering, AstraZeneca R&D, Granta Park, Cambridge, CB21 6GH, UK.
Tristan J VaughanDepartment of Antibody Discovery and Protein Engineering, AstraZeneca R&D, Granta Park, Cambridge, CB21 6GH, UK.
Ralph MinterDepartment of Antibody Discovery and Protein Engineering, AstraZeneca R&D, Granta Park, Cambridge, CB21 6GH, UK.ORCID http://orcid.org/0000-0001-5571-3102
Shabaz MohammedDepartment of Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU, UK.ORCID http://orcid.org/0000-0003-2640-9560
Wendy GibsonSchool of Biological Sciences, University of Bristol, Bristol, BS8 1UG, UK.
Martin C TaylorFaculty of Infectious and Tropical diseases, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK.ORCID http://orcid.org/0000-0003-4147-0693
Matthew K HigginsDepartment of Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU, UK. matthew.higgins@bioch.ox.ac.uk.ORCID http://orcid.org/0000-0002-2870-1955
Mark CarringtonDepartment of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QW, UK. mc115@cam.ac.uk.ORCID http://orcid.org/0000-0002-6435-7266
AstraZeneca (United Kingdom) · GBUniversity of Cambridge · GBUniversity of Oxford · GBCentre de Coopération Internationale en Recherche Agronomique pour le Développement · FRUniversity of Bristol · GBOxford Brookes University · GBUniversity of Edinburgh · GBUniversity of London · GB

Funding

JCSG Center:Innovative Membrane Protein Technology (RMI)P50GM073197 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI STEVENS, RAYMOND C · 2004 to 2013
$26.8M
Biotechnology and Biological Sciences Research Council BB/M008924/1Biotechnology and Biological Sciences Research Council BB/R010188/1Medical Research Council MR/P001424/1NIGMS NIH HHS P50 GM073197Wellcome TrustWellcome Trust 101020/Z/13/ZWellcome Trust 217138/Z/19/Z
6 · The paper itself

Abstract

Persistent pathogens have evolved to avoid elimination by the mammalian immune system including mechanisms to evade complement. Infections with African trypanosomes can persist for years and cause human and animal disease throughout sub-Saharan Africa. It is not known how trypanosomes limit the action of the alternative complement pathway. Here we identify an African trypanosome receptor for mammalian factor H, a negative regulator of the alternative pathway. Structural studies show how the receptor binds ligand, leaving inhibitory domains of factor H free to inactivate complement C3b deposited on the trypanosome surface. Receptor expression is highest in developmental stages transmitted to the tsetse fly vector and those exposed to blood meals in the tsetse gut. Receptor gene deletion reduced tsetse infection, identifying this receptor as a virulence factor for transmission. This demonstrates how a pathogen evolved a molecular mechanism to increase transmission to an insect vector by exploitation of a mammalian complement regulator.

Indexed as

AnimalsAntibodies, MonoclonalCattleCell MembraneCHO CellsComplement C3bComplement Factor HCricetinaeCricetulusMice, Inbred BALB CParasitemiaProtein BindingProtein DomainsProtozoan ProteinsReceptors, Cell SurfaceTrypanosomaAntibodies, MonoclonalComplement C3bComplement Factor HProtozoan ProteinsReceptors, Cell Surface

Identifiers

PMID32165615
PMCPMC7067766
OpenAlexW3011865457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.